Multiplex is taking over as main contractor on the £500m scheme to redevelop ITV’s former London headquarters on the South Bank. In an update, Vista – the name given to the job – said Multiplex had ...

Sure, here is the description with all links and additional text removed: If you found this video enjoyable, kindly show your support by giving it a thumbs up, leaving a comment, and subscribing for ...

Brain fog can be scary. It might appear innocently, like losing your car keys or forgetting what date you scheduled that appointment on. Some of this memory loss is normal—it’s just a natural side ...

The UEFA Champions League is set to wrap up its league phase this Wednesday, January 28, with a decisive eighth matchday played in a spectacular multiplex format. At 9 p.m., eighteen matches will be ...

In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers. When Elon Musk was at Davos last week, an interviewer asked him if he thought aging ...

The Multiplex Association of India has raised alarm over Netflix’s proposed acquisition of Warner Bros. Discovery, warning that the deal could diminish theatrical content availability and threaten ...

Add Futurism (opens in a new tab) Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Scientists say they’ve ...

Metabolic reprogramming in fibrotic lung diseases involves key metabolites like lactate, succinate, and 2-hydroxyglutarate, driving inflammation and fibroblast activation. Lactate accumulation ...

The cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise and powerful than ever. From curing genetic diseases to designing the next ...

Cancer cells can brainwash their neighbors. Like the CIA deploying secret agents to turn an enemy, tumors use a similar strategy to manipulate nearby cells. The tumors’ agents are mitochondria, the ...

A first-in-class antisense oligonucleotide — RES-010 (Resalis Therapeutics, Turin, Italy) — may complement and enhance the efficacy of antiobesity drugs such as GLP-1 receptor agonists (RAs), ...